Core Viewpoint - A class action securities lawsuit has been filed against MoonLake Immunotherapeutics, alleging securities fraud that affected shareholders between March 10, 2024, and September 29, 2025 [2][3]. Group 1: Lawsuit Details - The lawsuit claims that the defendants made false statements regarding their drug candidate SLK, asserting that it shares molecular targets with BIMZELX and that SLK's unique Nanobody structure does not provide superior clinical benefits [3]. - Allegations include that SLK's supposed increased tissue penetration would not lead to improved clinical efficacy, and thus the defendants lacked a reasonable basis for their positive claims about SLK's superiority over traditional monoclonal antibodies [3]. Group 2: Next Steps for Shareholders - Shareholders who experienced losses during the specified timeframe are encouraged to seek information on their rights to recovery, with no cost or obligation to participate [4]. Group 3: Legal Representation - Levi & Korsinsky LLP, a well-established securities litigation firm, has a strong track record in securing recoveries for shareholders and has been recognized as one of the top securities litigation firms in the United States [5].

Core Insights - Stride, Inc. is under investigation by Levi & Korsinsky for potential violations of federal securities laws following disappointing enrollment numbers and guidance despite beating earnings expectations [1][2]. Financial Performance - Stride reported its first quarter fiscal 2026 earnings on October 28, 2025, with earnings exceeding expectations; however, enrollment numbers and forward-looking guidance were significantly below expectations [2]. - The company has invested in upgrading its learning and technology platforms, but the implementations faced challenges, leading to higher withdrawal rates and lower conversion rates than anticipated [2]. Stock Market Reaction - Following the earnings report, Stride's stock price dropped by $68.51 per share, opening at $85.02 per share [3].

Core Points - A class action securities lawsuit has been filed against James Hardie Industries plc, targeting alleged securities fraud that affected shareholders between May 20, 2025, and August 18, 2025 [2][3] - The lawsuit claims that the company made false statements and concealed negative facts regarding its North America segment, including deteriorating consumer demand and excessive inventory issues [3] Company Details - The complaint alleges that the growth in James Hardie's North America segment was primarily driven by overstocking rather than genuine consumer demand, leading to excessive inventory at distributors [3] - The lawsuit seeks to recover losses for shareholders who were adversely affected during the specified time frame, regardless of whether they still hold their shares [4] Legal Representation - Levi & Korsinsky LLP, a nationally recognized securities litigation firm, is representing the shareholders in this case, boasting a strong track record in securing recoveries for aggrieved investors [5]

Core Viewpoint - A class action lawsuit has been filed against Inspire Medical Systems, Inc. for alleged securities fraud affecting shareholders between August 6, 2024, and August 4, 2025 [2]. Group 1: Lawsuit Details - The lawsuit claims that the company made false statements regarding the launch of its new product, Inspire V, which was reportedly unsuccessful due to poor demand and excess inventory at treatment centers [3]. - Allegations include that Inspire Medical Systems failed to complete essential tasks for a successful product launch, such as training for treatment center customers, setting up IT systems, and ensuring proper Medicare reimbursement [3]. Group 2: Next Steps for Affected Shareholders - Shareholders who experienced losses during the specified timeframe are encouraged to seek information on their rights to recovery, with no cost or obligation to participate [4]. Group 3: Legal Representation - Levi & Korsinsky LLP, a recognized securities litigation firm, has a history of securing significant recoveries for shareholders and has been ranked among the top securities litigation firms in the U.S. for seven consecutive years [5].

Core Viewpoint - A class action securities lawsuit has been filed against CarMax, Inc. alleging securities fraud that affected shareholders between June 20, 2025, and September 24, 2025 [2][3] Group 1: Lawsuit Details - The lawsuit claims that CarMax's management made false statements regarding the company's growth prospects, suggesting that the growth in the 2026 fiscal year was misleadingly attributed to temporary factors such as customer speculation about tariffs [3] - The complaint asserts that the statements made by the defendants about CarMax's business operations and future prospects were materially false and lacked a reasonable basis during the relevant time [3] Group 2: Next Steps for Affected Shareholders - Shareholders who experienced losses in CarMax stock during the specified period are encouraged to seek information about their rights to recovery, with no cost or obligation to participate [4] Group 3: Legal Representation - Levi & Korsinsky LLP, a recognized securities litigation firm, has a strong track record of securing significant recoveries for shareholders and has been ranked among the top securities litigation firms in the United States for seven consecutive years [5]

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of securities of Stride, Inc. for the period between October 22, 2024, and October 28, 2025, due to alleged misleading statements and omissions regarding the company's products and services [1][5]. Group 1: Lawsuit Details - The class action lawsuit claims that Stride, Inc. made misleading statements about its products and services aimed at public and private schools, which included inflated enrollment numbers and non-compliance with statutory requirements [5]. - Investors are entitled to compensation without any out-of-pocket fees through a contingency fee arrangement if they purchased Stride, Inc. securities during the Class Period [2]. Group 2: Next Steps for Investors - Investors wishing to join the class action can do so by visiting the provided link or contacting the law firm directly [3][6]. - A lead plaintiff must be appointed by January 12, 2026, to represent other class members in the litigation [1][3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [4]. - The firm has consistently ranked highly in securities class action settlements and has recovered hundreds of millions of dollars for investors [4].

Core Insights - High Tide Inc. is a leading cannabis enterprise focused on retail and community growth, operating the second-largest cannabis retail brand globally and supplying medical cannabis in Germany [3][4] - The company has been recognized for its growth, being named one of Canada's Top Growing Companies for five consecutive years and ranked as a top 50 company by the TSX Venture Exchange in 2022, 2024, and 2025 [4] Company Overview - High Tide operates through its subsidiary Canna Cabana and has multiple global e-commerce platforms for accessories and hemp-derived CBD products [3] - The company has achieved significant recognition, including being ranked number one in the retail category on the Financial Times list of America's Fastest Growing Companies for 2023 [4]

Company Overview - Reeflex Solutions Inc. is a Canadian company that provides advanced engineering and manufacturing solutions across various industry sectors [3] - The company operates through its wholly-owned subsidiary, Coil Solutions Inc., which offers coiled tubing injectors and downhole tools specifically for the oil and gas sector [3] - Reeflex's manufacturing division, Ranglar Manufacturing, specializes in custom-designed mobile equipment for a diverse range of industrial applications [3] Leadership Insights - John Babic, the President and CEO of Reeflex Solutions Inc., shared insights about the company's operations and strategies in an interview with TMX Group [1]

Toronto, Ontario--(Newsfile Corp. - Le 14 novembre/November 2025) - Energy Plug Technologies Corp. (PLUG) has announced a name and symbol change to Aegis Critical Energy Defence Corp. (QESS). Shares will begin trading under the new name and symbol and with a new CUSIP number on November 17, 2025. Disclosure documents are available at www.thecse.com. Please note that all open orders will be canceled at the end of business on November 14, 2025. Dealers are reminded to re-enter their orders. _________ ...

Core Insights - Alpha Cognition Inc. (NASDAQ: ACOG) has shown significant growth in the commercialization of its product ZUNVEYL® during Q3 2025, particularly in the U.S. long-term care (LTC) sector [1][7] - The company reported a 102% sequential increase in pharmacy orders, with over 600 nursing homes now covered and a prescriber base exceeding 500 clinicians [1][7] - Revenue for the quarter reached $2.8 million, driven by $2.3 million in net product sales from ZUNVEYL and $0.5 million in licensing revenue, indicating strong sequential growth [7] Company Performance - ZUNVEYL's launch momentum is accelerating, supported by a differentiated cognitive and behavioral profile and favorable tolerability signals observed in real-world use [1] - The LTC-focused field team is actively reinforcing the product's benefits, contributing to evidence of durable adoption and repeat ordering behavior in high-volume facilities [1] - Pro forma cash stands at approximately $73.2 million following an equity raise in October, providing about two years of operational runway at planned spending levels, bolstered by a $75 million ATM facility [7]